Michael R. Hayden - Dec 31, 2022 Form 5 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
Patrick R. O'Neil, attorney-in-fact, Michael R. Hayden
Stock symbol
IONS
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
5
Date filed
2/14/2023, 03:53 PM
Previous filing
Dec 5, 2022
Next filing
Feb 13, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding IONS Common Stock 23.1K Dec 31, 2022 Direct
holding IONS Common Stock 2K Dec 31, 2022 By Wife F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. Genworks 2 owned such shares of common stock on September 20, 2018, the date on which the reporting person became a director of Ionis Pharmaceuticals, Inc.